New Zealand markets close in 6 hours 9 minutes

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
104.83+0.02 (+0.02%)
At close: 04:00PM EDT
104.85 +0.02 (+0.02%)
After hours: 06:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.34B
Enterprise value 26.76B
Trailing P/E 21.88
Forward P/E 12.12
PEG ratio (5-yr expected) 1.38
Price/sales (ttm)2.89
Price/book (mrq)1.68
Enterprise value/revenue 3.56
Enterprise value/EBITDA 12.23

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-14.40%
S&P500 52-week change 320.52%
52-week high 3133.90
52-week low 3102.00
50-day moving average 3109.93
200-day moving average 3118.06

Share statistics

Avg vol (3-month) 31.59M
Avg vol (10-day) 31.57M
Shares outstanding 5203.65M
Implied shares outstanding 6203.65M
Float 8203.13M
% held by insiders 10.12%
% held by institutions 193.23%
Shares short (15 Aug 2024) 45.79M
Short ratio (15 Aug 2024) 43.78
Short % of float (15 Aug 2024) 43.23%
Short % of shares outstanding (15 Aug 2024) 42.84%
Shares short (prior month 15 Jul 2024) 45.82M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.92%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.92%
5-year average dividend yield 40.75
Payout ratio 420.04%
Dividend date 331 Oct 2024
Ex-dividend date 430 Sept 2024
Last split factor 2103:100
Last split date 301 Mar 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 13.25%
Operating margin (ttm)20.70%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)7.95%

Income statement

Revenue (ttm)7.52B
Revenue per share (ttm)36.37
Quarterly revenue growth (yoy)3.90%
Gross profit (ttm)N/A
EBITDA 2.52B
Net income avi to common (ttm)997.1M
Diluted EPS (ttm)4.79
Quarterly earnings growth (yoy)15.80%

Balance sheet

Total cash (mrq)420.1M
Total cash per share (mrq)2.06
Total debt (mrq)6.03B
Total debt/equity (mrq)47.33%
Current ratio (mrq)1.29
Book value per share (mrq)62.18

Cash flow statement

Operating cash flow (ttm)1.52B
Levered free cash flow (ttm)1.04B